0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology

Buy Now

Antiviral Chemotherapy 4 - New Directions for Clinical Application and Research (Paperback, Softcover reprint of the original 1st ed. 1996) Loot Price: R5,809
Discovery Miles 58 090
Antiviral Chemotherapy 4 - New Directions for Clinical Application and Research (Paperback, Softcover reprint of the original...

Antiviral Chemotherapy 4 - New Directions for Clinical Application and Research (Paperback, Softcover reprint of the original 1st ed. 1996)

John Mills, Paul A. Volberding, Lawrence Corey

Series: Advances in Experimental Medicine and Biology, 394

 (sign in to rate)
Loot Price R5,809 Discovery Miles 58 090 | Repayment Terms: R544 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The three years since our last conference in San Francisco have again seen a dramatic expansion of the number of antivirals either licensed or in the late stages of clinical trials. d4T is now licensed for HIV infection, famciclovir and the oral pro-drug of acyclovir, valacyclovir, are now licensed for VZV infections in some countries. Moreover. oral ganciclovir, cidofovir, and sorivudine are not far behind. Clinical trials with the second-site reverse transcriptase inhibitors and the protease inhibitors for HlV infection are proceeding rapidly and on a broad scale, and the preliminary results would suggest that several of these classes of drugs will be licensed as well. Despite this optimism, however, there is increasing evidence that antiviral-resistant strains of pathogenic viruses will be a significant problem, perhaps especially with therapy of HIV infection, and there remains a desperate need for improved drugs (with either improved efficacy or decreased toxicity, or both) for CMV and HIV infections. This book is the edited proceedings of the Fourth Triennial Conference on Antiviral Chemotherapy, held in San Francisco, in November 1994. The conference was sponsored by the University of California, San Francisco, and co-sponsored by the International Society for Antiviral Research (ISAR), the Macfarlane Burnet Centre for Medical Research in Melbourne, Australia, and the Australian National Centre for HIV Virology Research. The conference had been organized to present an overview of the field of antiviral chemotherapy.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Advances in Experimental Medicine and Biology, 394
Release date: April 2013
First published: 1996
Editors: John Mills • Paul A. Volberding • Lawrence Corey
Dimensions: 235 x 155 x 23mm (L x W x T)
Format: Paperback
Pages: 440
Edition: Softcover reprint of the original 1st ed. 1996
ISBN-13: 978-1-4757-9211-9
Categories: Books > Medicine > Nursing & ancillary services > Pharmacy / dispensing
Books > Medicine > Other branches of medicine > Pharmacology > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN: 1-4757-9211-5
Barcode: 9781475792119

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners